LONGS DRUG STORES CORP
DEF 14A, 1994-04-14
DRUG STORES AND PROPRIETARY STORES
Previous: SEALY CORP, 10-Q, 1994-04-14
Next: DOLLAR FINANCE INC, 10-Q, 1994-04-14



<PAGE>
                            SCHEDULE 14A INFORMATION

                  Proxy Statement Pursuant to Section 14(a) of
                      the Securities Exchange Act of 1934

    Filed by the Registrant /X/
    Filed by a Party other than the Registrant / /
    Check the appropriate box:
    / /  Preliminary Proxy Statement
    /X/  Definitive Proxy Statement
    / /  Definitive Additional Materials
    / /  Soliciting  Material  Pursuant  to  Section  240.14a-11(c)  or  Section
         240.142-12

                         Longs Drug Stores Corporation
- --------------------------------------------------------------------------------
                (Name of Registrant as Specified In Its Charter)

                         Longs Drug Stores Corporation
- --------------------------------------------------------------------------------
                   (Name of Person(s) Filing Proxy Statement)

Payment of Filing Fee (Check the appropriate box):

/X/  $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), or 14a-6(i)(2)
/ /  $500 per  each party  to  the controversy  pursuant  to Exchange  Act  Rule
     14a-6(i)(3)
/ /  Fee   computed  on   table  below   per  Exchange   Act  Rules  14a-6(i)(4)
     and 0-11
     1) Title of each class of securities to which transaction applies:


        ------------------------------------------------------------------------
     2) Aggregate number of securities to which transaction applies:


        ------------------------------------------------------------------------
     3) Per unit  price  or  other  underlying  value  of  transaction
        computed pursuant to Exchange Act Rule 0-11:*


        ------------------------------------------------------------------------
     4) Proposed maximum aggregate value of transaction:


        ------------------------------------------------------------------------
*    Set forth the amount on which the filing fee is calculated and state how it
     was determined.
/ /  Check box if any part of the fee is offset as provided by Exchange Act Rule
     0-11(a)(2)  and identify the  filing for which the  offsetting fee was paid
     previously. Identify the previous filing by registration statement  number,
     or the Form or Schedule and the date of its filing.

     1) Amount Previously Paid:


        ------------------------------------------------------------------------
     2) Form, Schedule or Registration Statement No.:


        ------------------------------------------------------------------------
     3) Filing Party:


        ------------------------------------------------------------------------
     4) Date Filed:


        ------------------------------------------------------------------------

<PAGE>
                 NOTICE OF 1994 ANNUAL MEETING OF SHAREHOLDERS

                      [LONGS DRUG STORES CORPORATION LOGO]

    The  Annual Meeting of Shareholders of Longs Drug Stores Corporation will be
held at  the Regional  Center for  the  Arts, 1601  Civic Drive,  Walnut  Creek,
California,  on Tuesday, May  17, 1994, at  11:00 a.m., for  the purposes of (1)
electing four directors; (2) voting on a proposal to approve the 1995  Long-Term
Incentive  Plan;  and (3)  transacting such  other business  as may  properly be
brought before the meeting or any adjournment thereof.

    Only shareholders of record  at the close of  business on Tuesday, April  5,
1994, will be entitled to vote at the meeting.

    If  you are unable to  be present, you are requested  to vote your shares by
signing the enclosed proxy and returning it in the envelope provided.

Walnut Creek, California
April 15, 1994

                                                   ORLO D. JONES
                                                   Secretary
<PAGE>
                      [LONGS DRUG STORES CORPORATION LOGO]

                               EXECUTIVE OFFICES
                             141 NORTH CIVIC DRIVE
                         WALNUT CREEK, CALIFORNIA 94596

                                PROXY STATEMENT

    The following information is submitted concerning the enclosed proxy and the
matters  to be acted  upon at the  Annual Meeting of  Shareholders of Longs Drug
Stores Corporation  (the  "Company")  to  be  held  on  May  17,  1994,  or  any
adjournment thereof, pursuant to the Notice of said meeting.

    The  approximate date on  which this Proxy  Statement and form  of proxy are
first being sent or given to shareholders is April 15, 1994.

                          INFORMATION CONCERNING PROXY

    The proxy is solicited on behalf of  the Board of Directors of the  Company.
It  may be revoked at any time before  its exercise by filing with the Secretary
of the Company a  written revocation or  a duly executed  proxy bearing a  later
date.  It may also be revoked by attendance  at the meeting and election to vote
in person.

    D.F. King &  Co., Inc. has  been engaged  to assist in  the solicitation  of
proxies  from  brokers,  banks,  institutions,  and  other  shareholders  for an
anticipated fee of approximately $5,000, plus out-of-pocket costs and  expenses.
Certain  directors, officers, and  regular employees of  the Company may solicit
proxies by mail, telephone, telegraph, or personal interview. The entire cost of
solicitation of proxies will be borne by the Company.

    As of  April 5,  1994, the  Company had  20,850,197 shares  of Common  Stock
outstanding.  Only shareholders of record  at the close of  business on April 5,
1994, will be entitled to  notice of, and to vote  at, the Annual Meeting.  Each
share is entitled to one vote. A plurality of all the votes cast at the meeting,
with  a quorum present, is sufficient to elect a director and a plurality of all
votes cast  is required  for  approval of  the  1995 Long-Term  Incentive  Plan.
Abstentions  and  broker non-votes  will not  be considered  votes cast  for the
foregoing purposes.

 SECURITY OWNERSHIP OF DIRECTORS, EXECUTIVE OFFICERS AND PRINCIPAL STOCKHOLDERS

    The following table presents  the number of shares  of the Company's  Common
Stock owned beneficially as of April 5, 1994, by each director and nominee, each
of the five most highly compensated executive officers for the fiscal year ended
January  27, 1994, and all  directors and executive officers  as a group, and by
all other persons known by the Company  to beneficially own more than 5% of  the
Company's Common Stock.

                                       1
<PAGE>

<TABLE>
<CAPTION>
                                                                   SHARES BENEFICIALLY OWNED(1)
                                                                 --------------------------------
NAME(2)                                                            COMMON STOCK      % OF CLASS
- ---------------------------------------------------------------  -----------------  -------------
<S>                                                              <C>                <C>
R.M. Long......................................................    2,079,931(3)           10.0%
V.M. Long......................................................    1,996,073(5)            9.6%
Thomas J. Long Foundation......................................    1,758,007(4)            8.4%
J.M. Long Foundation...........................................      658,550(7)            3.2%
Ariel Capital Management, Inc..................................    2,522,295(6)           12.1%
B. Brandon.....................................................       19,791              *
R. Brooks......................................................        2,100              *
W. Combs.......................................................        8,540              *
D. DeSchane....................................................       22,500              *
E. Johnston....................................................          500              *
O. Jones.......................................................       12,026              *
M. Metz........................................................          130              *
R. Plomgren....................................................       42,481(8)           *
S. Roath.......................................................       31,040              *
H. Somerset....................................................          100              *
T. Sweeney.....................................................       44,563              *
F. Trotter.....................................................          300              *
All directors and executive officers as a group
  (16 persons).................................................    4,731,340(9)(11)       22.7%
Employees' Profit Sharing Plan and
  Variable Investment Plan.....................................    3,267,187              15.7%
<FN>
- ------------------------
*     Less than 1%.
 (1)  Participants  in  the  Employees'  Profit Sharing  Plan  and  the Variable
      Investment Plan have the right to direct  the trustee as to the voting  of
      the shares of the Company's Common Stock that have been allocated to their
      respective  stock accounts,  and as  such have  voting power  with respect
      thereto. The  beneficial ownership  of each  individual included  in  this
      table  who is a participant in the  plans includes the shares held in that
      person's stock accounts under the plans. The aggregate number of shares so
      included for all such individuals is  26,861, and the maximum so  included
      for  any individual is 8,341. See note 10 below. Beneficial ownership also
      includes the  shares of  restricted stock  held by  executive officers  in
      respect of which shares the executive officers have voting power. See note
      1  to the  Summary Compensation Table  below for the  shares of restricted
      stock held by  the listed executive  officers. The persons  named in  this
      table  have sole voting  and investment powers with  respect to the shares
      indicated, except as  otherwise noted  and subject  to community  property
      laws, where applicable.
 (2)  Except  as otherwise noted, the address  for all beneficial owners of more
      than five percent of the Company's  stock is P.O. Box 5222, Walnut  Creek,
      California 94596.
 (3)  Includes  122,664 shares held in fiduciary capacity for family members and
      other relatives for which R.M. Long  has sole voting and investment  power
      and  43,313 shares held in fiduciary capacity for family members for which
      R.M. Long has shared  voting and investment power  with E. Long.  Excludes
      7,456  shares  held  by  family members.  R.M.  Long  disclaims beneficial
      ownership of all shares referenced  above. Also includes 1,500,000  shares
      held  in fiduciary capacity for which R.M.  Long has sole voting power and
      shared investment power with V.M. Long.
 (4)  T. Sweeney & W. Combs, with others  serve as co-trustees of the Thomas  J.
      Long  Foundation,  and therefore  share investment  and voting  power over
      these 1,758,007 shares. These shares do not appear separately in the table
      for any  of  these  individuals  and each  of  them  disclaims  beneficial
      ownership thereof.
 (5)  Includes  1,500,000 shares as  to which V.M.  Long shares investment power
      with R.M. Long. Such  shares appear in  the table for  both V.M. Long  and
      R.M. Long.
 (6)  The  address of Ariel Capital Management, Inc., is 307 N. Michigan Avenue,
      Chicago, Illinois 60601.
</TABLE>

                                       2
<PAGE>
<TABLE>
<S>   <C>
 (7)  Four of the  five co-trustees  of the  J.M. Long  Foundation include  R.M.
      Long,  W. Combs, O. Jones, and S. Roath and they therefore share, with all
      co-trustees, investment and voting power over these 658,550 shares.  These
      shares  do not appear separately in the table for any of these individuals
      and each of them disclaims beneficial ownership thereof.
 (8)  Does not include certain shares held by the Employees' Profit Sharing Plan
      and the Variable Investment Plan in respect of which Mr. Plomgren may have
      shared voting power by virtue of his membership on the Policy Committee of
      such plans, and of  which he disclaims beneficial  ownership. See note  10
      below.
 (9)  Includes  the 1,758,077 shares  held by the Thomas  J. Long Foundation and
      the 658,550 shares held by the J.M. Long Foundation because certain of the
      trustees of  each  entity  are  directors or  executive  officers  of  the
      Company.
(10)  Bank  of America National Trust and  Savings Association is the trustee of
      the Employees' Profit Sharing Plan  and the Variable Investment Plan.  The
      Policy  Committee for both  of the plans  has the authority  to direct the
      trustee as to the voting of allocated whole shares of the Company's Common
      Stock for  which  no voting  instructions  are timely  received  from  the
      participant,  the  aggregate  number  of  fractional  shares  allocated to
      participants' accounts and all unallocated shares. As such, the members of
      the Policy  Committee may  be  deemed to  have  shared voting  power  with
      respect  to such shares.  On April 5,  1994, the aggregate  number of such
      fractional and unallocated shares in the plans was 376,284.
(11)  Section 16(a)  of  the  Securities  Exchange  Act  of  1934  requires  the
      Company's  officers  and  directors, and  persons  who own  more  than ten
      percent of a registered class of the Company's equity securities, to  file
      reports  of ownership  and changes  in ownership  with the  Securities and
      Exchange  Commission   (SEC).  Officers,   directors  and   greater   than
      ten-percent  shareholders are  required by  SEC regulation  to furnish the
      Company with copies of all Section 16(a) forms they file. Based solely  on
      its  review  of the  copies  of such  forms  received by  it,  the Company
      believes that, for  the period April  7, 1993 through  April 5, 1994,  all
      filing  requirements applicable  to its  officers, directors,  and greater
      than ten-percent beneficial owners were complied with, except that a  Form
      4 covering the sale of 1,000 shares was filed late by Mr. D.W. Wilson, who
      did  report the transaction  in his year-end  report on Form  5, which was
      timely filed.
</TABLE>

                         ITEM I. ELECTION OF DIRECTORS

    The Board of Directors  consists of eleven  members, the maximum  authorized
membership,  divided into three classes. Four directors, as set forth below, are
to be elected at the Annual Meeting. The remaining seven directors will continue
to serve as set forth below. The proxy holders will vote the proxies received by
them for the following  four nominees for  the terms set  below and until  their
successors  are duly  elected and  qualified (unless  authorization to  vote for
election of  directors  has been  withheld).  The four  nominees  receiving  the
greatest  number  of votes  will be  elected  as directors  of the  Company. The
Company is unaware of any nominee who would be unavailable to serve if  elected.
In  the event  that any nominee  shall be unable  to serve, the  proxies will be
voted by the proxy  holders for such  other person as may  be designated by  the
Board of Directors.

    The following sets forth information as to each nominee for election at this
meeting  and each director  continuing in office,  including their ages, present
principal occupations and those held  during the last five years,  directorships
in  other publicly held  corporations, membership in committees  of the Board of
Directors, and the year in  which each first became  a director of the  Company.
All occupations listed refer to the Company unless otherwise stated.

                     NOMINEES FOR ELECTION AT THIS MEETING:
                           (TERMS TO EXPIRE MAY 1997)

        S.D.  Roath, 53, President and Director.  Prior to becoming President he
    was Executive Vice President.  He has been a  Director of the Company  since
    1979.

        E.E.  Johnston,  76, Insurance  Consultant;  and Director.  Mr. Johnston
    chairs the  Audit  Committee  and  is  a  member  of  the  Stock  Investment
    Committee,  the Nominating Committee,  and the Stock  Bonus and Compensation
    Review Committee. He has been a Director of the Company since 1980.

                                       3
<PAGE>
        T.R. Sweeney, 55,  Retired Vice  President and District  Manager of  the
    Company; and Director. He has been a Director of the Company since 1978.

        M.S. Metz, Ph.D., 56, Dean, U.C. Berkeley Extension, and Director. Prior
    thereto  she was a Consultant and President  of Mills College. Dr. Metz is a
    Director of  Pacific  Gas and  Electric  Company, Union  Bank,  and  Pacific
    Telesis  Group. Dr. Metz  is a member  of the Audit  Committee and the Stock
    Bonus and Compensation  Review Committee.  She has  been a  Director of  the
    Company since 1991.

                 DIRECTORS WHOSE PRESENT TERMS EXPIRE MAY 1995:

        R.M.  Long,  55, Chairman  of the  Board,  Chief Executive  Officer, and
    Director. Prior thereto he  was President and  Chief Executive Officer.  Mr.
    Long  chairs the Nominating Committee. He has been a Director of the Company
    since 1968.

        R.A. Plomgren, 60, Senior Vice President -- Development and Director. He
    has been a Director of the Company since 1972.

        F.E. Trotter, 63,  President, F.E.  Trotter, Inc.;  and Director.  Prior
    thereto  he was Trustee  of the Estate  of James Campbell.  Mr. Trotter is a
    Director of Bancorp Hawaii,  Inc., Bank of  Hawaii, Hawaii Bancorp  Leasing,
    and  Maui  Land and  Pineapple  Co. Mr.  Trotter is  a  member of  the Audit
    Committee. He has been a Director of the Company since 1989.

        H.R. Somerset, 58,  Business Consultant and  Director. Prior thereto  he
    was  President and  Chief Executive  Officer, California  and Hawaiian Sugar
    Company; prior thereto he was  Executive Vice President and Chief  Operating
    Officer  of California and Hawaiian Sugar  Company. Mr. Somerset is a member
    of the Audit Committee, the  Stock Bonus and Compensation Review  Committee,
    and  the Stock Investment Committee.  He has been a  Director of the Company
    since 1992.

                 DIRECTORS WHOSE PRESENT TERMS EXPIRE MAY 1996:

        W.G.  Combs,  63,  Vice  President  --  Administration,  Treasurer,  and
    Director. He has been a Director of the Company since 1980.

        R.M.  Brooks, 65, Financial  Consultant; and Director.  Prior thereto he
    was President and Chief Executive Officer of SFA Management Corporation. Mr.
    Brooks is a  Director of  BEI Electronics, Inc.,  and Granite  Construction,
    Inc. Mr. Brooks chairs the Stock Bonus and Compensation Review Committee and
    the  Stock Investment Committee, and is a  member of the Audit Committee and
    the Nominating Committee. He has been a Director of the Company since 1988.

        D.G. DeSchane, 69, Retired  Vice President and  District Manager of  the
    Company;  and Director.  Mr. DeSchane  is a  member of  the Stock  Bonus and
    Compensation Review Committee. He has been  a Director of the Company  since
    1990.

                             THE BOARD OF DIRECTORS

    During  the fiscal year ended  January 27, 1994, the  Board of Directors met
five times. During the fiscal year, each director attended more than 75% of  all
meetings of the Board and the Committees upon which they served.

                            COMMITTEES OF THE BOARD

    The  Audit  Committee is  composed entirely  of non-employee  directors. The
current Committee  members are  E.E. Johnston  (Chairman), H.R.  Somerset,  F.E.
Trotter, M.S. Metz, and R.M. Brooks. The Audit Committee's primary functions are
to   monitor  the   Company's  accounting,  financial   reporting,  and  control
procedures, and to recommend the independent certified public accountants to  be
selected  by the  Company. The  Committee met two  times during  the fiscal year
ended January 27, 1994.

    The Stock Bonus and  Compensation Review Committee establishes  compensation
for  the Company's senior executive officers and administers the Company's stock
option plans and the Company's long term

                                       4
<PAGE>
incentive plans. The current Committee members are R.M. Brooks (Chairman),  D.G.
DeSchane,  E.E. Johnston,  M.S. Metz, and  H.R. Somerset. The  Committee met two
times during the fiscal year ended January 27, 1994.

    The Nominating Committee recommends to the Board of Directors candidates for
directors of  the  Company. The  Committee  will consider  qualified  candidates
including  those submitted  by shareholders. Shareholder  recommendations may be
submitted to  the  Secretary  in  accordance with  the  Company's  By-Laws.  The
Committee  did  not meet  during the  fiscal  year ended  January 27,  1994. The
current Committee  members  are R.M.  Long  (Chairman), R.M.  Brooks,  and  E.E.
Johnston.

    The  Stock Investment Committee  is responsible for  advising the Trustee of
the  Employees'  Profit  Sharing  Plan  ("Profit  Sharing  Plan")  and  Variable
Investment  Plan regarding  the price  and other  terms and  conditions of block
purchases of the Company's stock. The Committee met four times during the fiscal
year ended  January 27,  1994. The  current Committee  members are  R.M.  Brooks
(Chairman), H.R. Somerset, and E.E. Johnston.

                             EXECUTIVE COMPENSATION

    The  table below sets forth the compensation earned by the following persons
during the fiscal years  ended January 27, 1994,  January 28, 1993, and  January
30,  1992,  for services  rendered  in all  capacities  to the  Company  and its
subsidiaries: (i) the chief executive officer (CEO) of the Company, and (ii) the
four other most highly compensated executive officers of the Company.

                           SUMMARY COMPENSATION TABLE

<TABLE>
<CAPTION>
- ------------------------------------------------------------------------------------------------------------------
                                                                                    LONG-TERM
                                                                                  COMPENSATION
                                                    ANNUAL COMPENSATION              AWARDS
                                             ----------------------------------  ---------------
                                                                   OTHER ANNUAL    RESTRICTED         ALL OTHER
                                     FISCAL                        COMPENSATION       STOCK        COMPENSATION(2)
  NAME AND PRINCIPAL POSITION         YEAR   SALARY($)   BONUS($)      ($)       AWARD(S)(1)($)          ($)
- -----------------------------------  ------  ----------  --------  ------------  ---------------  ------------------
<S>                                  <C>     <C>         <C>       <C>           <C>              <C>
 R.M. Long--CEO & Chairman of the     1994   $  103,000  $282,610  $    2,242                     $        3,115
  Board                               1993      100,000   306,570       2,395                              2,926
                                      1992      100,000   321,130       2,090                              3,713
  S.D. Roath--President               1994   $   92,700  $252,330  $    2,242                     $        3,115
                                      1993       90,000   273,184       2,395                              2,926
                                      1992       70,000   263,800       2,090           181,875            3,713
  R.A. Plomgren--Senior Vice          1994   $   82,400  $171,590  $    2,242                     $        3,115
   President-- Development            1993       80,000   186,130       2,395                              2,926
                                      1992       70,000   183,500       2,090                              3,713
  O.D. Jones--Senior Vice             1994   $   82,400  $131,200  $    2,242                     $        3,115
   President--Properties              1993       80,000   142,330       2,395                              2,926
                                      1992       70,000   137,630       2,090                              3,713
  B.M. Brandon--Senior Vice           1994   $   72,100  $121,120  $    2,242                     $        3,115
   President                          1993       70,000   131,390       2,395                              2,926
                                      1992       62,308   131,300       2,090                              3,713
- -----------------------------------------------------------------------------------------------------
<FN>
- --------------------------
(1)  The number and value (based on the last reported sale price on January  27,
     1994),  of the aggregate  restricted stock holdings  of the named executive
     officers at the end of fiscal 1994 were: R.M. Long, 2,500 shares ($83,750);
     S.D. Roath, 7,500 shares ($251,250); R.A. Plomgren, 2,500 shares ($83,750);
     O.D.  Jones,  2,500  shares  ($83,750);  and  B.M.  Brandon,  3,000  shares
     ($100,500). Dividends paid on restricted shares are retained by the Company
     and,  when the restricted shares vest, the retained dividends thereon, plus
     interest earned from the Company's investment of dividends, are paid to the
     recipient.
(2)  Comprised entirely of  Company contributions  for the  indicated year  that
     were  allocated to the named executive  officer's account in the Employee's
     Profit Sharing Plan.
</TABLE>

                                       5
<PAGE>
            AGGREGATED OPTIONS/SAR EXERCISES IN THE LAST FISCAL YEAR
                     AND FISCAL YEAR-END OPTION/SAR VALUES

<TABLE>
<CAPTION>
                                                                                         VALUE OF
                                                                           NUMBER OF   UNEXERCISED
                                                  SHARES                  UNEXERCISED  IN-THE-MONEY
                                                ACQUIRED ON     VALUE     OPTIONS AT    OPTIONS AT
                     NAME                        EXERCISE     REALIZED     FY-END 94    FY-END 94
<S>                                             <C>          <C>          <C>          <C>
 S.D. Roath--President........................       1,000   $  10,440(a)     --            --
<FN>
- ------------------------
(a)  Based on the difference  between the exercise price  of $22.1875 per  share
     and the market price on the date of exercise.
</TABLE>

                            DIRECTORS' COMPENSATION

    Directors  who are employees of the Company or any subsidiary of the Company
receive no additional compensation for  their services as directors. Each  other
member  of the  Board is  paid an annual  retainer of  $26,000.00 plus  a fee of
$900.00 for each Board meeting attended. Each director who is not an employee of
the Company or any subsidiary of the Company receives $900.00 for each Committee
meeting attended. Each Committee Chairman  receives an additional annual fee  of
$4,000.00 for each such position held.

                             TERMINATION AGREEMENTS

    The  Subsidiary has entered into Agreements  with the officers identified in
the table under the  caption "Executive Compensation" on  page 5, and 296  other
officers  and  key  employees  of the  Subsidiary  which  provide  for severance
payments to such officers and employees in  the event of their discharge by  the
Subsidiary at any time within two years after the date of an Uninvited Change in
Control  (as defined) or a resignation of  the executive or employee at any time
within the period commencing  180 days and ending  two years after an  Uninvited
Change  in Control. The severance benefits  payable to the executive or employee
would be equal  to three times  the annual  average income of  the executive  or
employee  during the  five taxable  years preceding  the date  of termination of
employment. For purposes of  the Agreements, Uninvited  Change in Control  means
any  change  in  the  ownership  or effective  control  of  the  Company  or any
subsidiary or  the ownership  of a  substantial  portion of  the assets  of  the
Company  or any subsidiary,  which change is  not approved by  a majority of the
directors of the Company who  have been in office at  least six months prior  to
the date of such change.

    If an Uninvited Change in Control had occurred on December 31, 1993, and all
executives  and other employees covered by the Agreements had been discharged by
the Company, Messrs. R.M. Long, S.D.  Roath, R.A. Plomgren, O.D. Jones and  B.M.
Brandon  would have been  entitled to receive  $1,244,163, $1,005,297, $760,902,
$616,056, and $555,825, respectively. All  other officers and employees  covered
by the Agreements would have been entitled to receive $61,553,553.

                           REPORT OF THE STOCK BONUS
                       AND COMPENSATION REVIEW COMMITTEE

    The  Stock Bonus and Compensation Review  Committee consists of five members
of the Board,  none of whom  is an employee  of the Company.  One member, D.  G.
DeSchane,  who retired  in 1988, is  a former officer  of the Company  and T. J.
Long, a  member of  the Committee  prior to  his death  in April,  1993, was  an
officer  until retiring in  1975. The purpose  of the Committee  is to establish
compensation  for  the  Company's  executive  officers  and  to  administer  the
Company's long-term incentive plans.

    In  compensating  executives,  including the  Chief  Executive  Officer, the
Company's policy has been to employ a straightforward compensation program under
which  a  significant  portion  of   compensation  is  tied  to  the   Company's
performance.  Given the stability  of the senior  management team, the Committee
believes  that  this  approach  provides  an  appropriate  incentive  to  senior
management  to  continually  strive  to  increase  long-term  profitability. The
Committee recognizes  that  management  compensation  is  a  key  ingredient  in
attracting  and retaining capable  leadership and that  the compensation program
must afford management the opportunity to earn a level of compensation that they
will find acceptable.

                                       6
<PAGE>
    The major  components  of executive  compensation  consist of  base  salary,
bonus,  and  awards under  the Company's  equity  plans. Salaries  for executive
officers are set at levels  that the Committee believes,  based on its study  of
comparative  industry  data, are  relatively low  for  the senior  management of
large, publicly traded retail businesses. The companies surveyed for the sake of
this comparison have included virtually all of the peer group companies included
in the chart appearing under  "Performance Graph" below, and certain  additional
grocery  and  general  merchandise  retailers,  although  the  precise  group of
companies surveyed may vary slightly from year to year. Base annual salaries for
executive officers in the fiscal year ended January 27, 1994, ranged from 67,000
to $103,000.

    The more significant component of  cash compensation is the Company's  bonus
program.  Under this program the  Committee establishes an applicable percentage
of the Company's operating income before provisions ("OIBP") for each  executive
officer  at the  beginning of each  year. OIBP is,  essentially, earnings before
taxes, profit sharing  contributions, senior officer  bonuses, and any  required
LIFO  adjustment. The  bonus program  is designed  to produce  cash compensation
(i.e. salary  and  bonus) that  the  committee  believes, based  on  the  survey
described in the preceding paragraph, is in the lower end of the range of annual
compensation  for senior management in  large, publicly traded retail businesses
if the Company achieves  target levels of OIBP.  The applicable percentages  are
arrived  at on the basis  of the percentage of  budgeted OIBP necessary to reach
the target range. A cash bonus is paid quarterly to the officer in the amount of
his applicable  percentage  of OIBP  for  that quarter.  Bonuses  for  executive
officers  in the  fiscal year  ended January 27,  1994, ranged  from $106,000 to
$283,000. These  bonuses  accounted  for  approximately  60-65%  of  total  cash
compensation  for Senior Vice Presidents and  73% of total cash compensation for
the Chairman and Chief  Executive Officer and the  President. The Committee  has
not  established limits on the percentage  of cash compensation that may consist
of these bonuses.

    The third component of  executive compensation is  the periodic granting  of
equity  based awards under  the Company's Long-Term Incentive  Plan of 1987 and,
assuming approval by the shareholders, the 1995 Long-Term Incentive Plan. Awards
under these  plans  can include  restricted  stock, stock  options,  performance
shares and stock appreciation rights and can be made to key employees, including
executive  officers, key general office employees  and the top three managers in
most stores. Prior  awards to executive  officers under the  1987 plan have  had
five year vesting periods. These plans are intended to provide compensation that
will  be an incentive to  key employees to enhance  the profitable growth of the
Company and the value of its common stock. While the range of award sizes  among
participants  has been relatively modest, the difference in size of awards under
the plans has been based primarily on the general level of responsibility of the
recipient. The Committee may also consider subjective factors on a case by  case
basis  as it believes to  be in the Company's  best interests. Awards made under
the 1987  plan have  been  a relatively  small  component of  executive  officer
compensation.  Since the adoption  of the 1987  plan, through the  end of fiscal
1994 awards totaling  5,000 shares  of restricted stock  have been  made to  the
Chief  Executive  Officer  and  each  other  executive  officer  other  than the
President, to whom an  aggregate of 10,000 shares  of restricted stock has  been
awarded.  Approximately 250,000 additional shares  of restricted stock have been
granted to the other recipients  under the 1987 plan.  No awards have been  made
under the 1995 plan.

    The  compensation of the  Company's Chief Executive  Officer for fiscal 1994
has been established  in accordance  with the foregoing  procedures. For  fiscal
1994  the Chief Executive  Officer's compensation consisted  of his base salary,
constituting approximately  27%  of annual  compensation,  and bonus.  The  base
salary included an increase of three percent over the prior year, as this salary
had not been increased since 1988. The bonus declined from the prior year as his
percentage  of OIBP (applicable percentage) was set  at the same level as in the
prior year and OIBP declined from fiscal 1993 to fiscal 1994.

<TABLE>
<S>                                        <C>
R. M. Brooks (Chairman)                    D. G. DeSchane
E. E. Johnston                             H. R. Somerset
M. S. Metz
</TABLE>

                       COMPENSATION COMMITTEE INTERLOCKS
                           AND INSIDER PARTICIPATION

    The Stock Bonus and Compensation  Review Committee consists of five  members
of  the Board, none  of whom is  an employee of  the Company. One  member, D. G.
DeSchane, who retired in 1988, is a former

                                       7
<PAGE>
officer of the Company and  T. J. Long, a member  of the Committee prior to  his
death  in April, 1993, was an officer  until retiring in 1975. The other members
of the committee are R.M. Brooks, E.E. Johnston, M.S. Metz and H.R. Somerset.

                               PERFORMANCE GRAPH

    The graph below indicates the cumulative total shareholder return, including
reinvestment of dividends,  over the  last five  fiscal years.  The stock  price
performance shown is not necessarily indicative of future price performance.

             COMPARISON OF FIVE-YEAR CUMULATIVE TOTAL RETURN AMONG
         LONGS DRUG STORES, S&P 500 INDEX, AND NATIONAL ASSOCIATION OF
          CHAIN DRUG STORES ("NACDS") PEER GROUP INDEX AND PEER GROUP.

<TABLE>
<CAPTION>
                                       NACDS PEER
X AXIS NAME                               GROUP       S&P 500    LONGS DRUG
- -------------------------------------  -----------  -----------  -----------
<S>                                    <C>          <C>          <C>
JAN 89...............................      100.00        100.00      100.00
JAN 90...............................      107.21        114.45      115.69
JAN 91...............................      131.47        124.07      143.42
JAN 92...............................      165.90        152.23      158.67
JAN 93...............................      172.89        168.33      148.11
JAN 94...............................      173.03        190.01      135.51
</TABLE>

    * The  peer  groups used  for  1993 and  1994  differ slightly  in their
      composition, as  further  explained  in the  paragraph  following  the
      graph.

    At  the time of its preparation of  its 1993 proxy statement, the NACDS Peer
Group Index had not  been finally established.  Therefore, in the  corresponding
graph in its fiscal 1993 Proxy Statement the Company used a Peer Group comprised
of  the  following companies,  which the  Company had  anticipated would  be the
companies included in  the NACDS  Index, Arbor Drugs,  Inc.; Big  B, Inc.;  Drug
Emporium,  Inc.; Fay's  Incorporated; Genovese  Drug Stores,  Inc.; Hook-SupeRx,
Inc.; Longs Drug Stores; Medicine Shoppe;  Perry Drug Stores, Inc.; Revco  D.S.,
Inc.;  Rite Aid Corp.; and Walgreen Co. The NACDS Index has now become available
and includes one company (F&M Distributors) not in the Peer Group Index used  by
the Company in fiscal 1993 and does not include one company included in the 1993
Peer  Group Index (Medicine Shoppe). Rounding to the nearest dollar, the returns
indicated in the NACDS Index  and the 1993 Peer  Group Index are identical  over
the five year period shown in the graph.

                 ITEM 2. 1995 LONG-TERM INCENTIVE PLAN-SUMMARY

GENERAL

    The  1995 Long-Term Incentive Plan  ("Plan") is an equity  based plan of the
Company designed to  attract and retain  the employment of  able persons and  to
strengthen  the commitment of such persons to the Company by providing them with
equity or equity based ownership.

    The Plan is substantially similar to the Company's Long-Term Incentive  Plan
of  1987 approved  by shareholders in  May 1986.  The 1987 plan  allowed for the
grant of an aggregate of 400,000 shares or share based awards, and as of the end
of fiscal 1994, 108,000  shares remained available for  future grant under  that
plan  (exclusive of outstanding  unvested shares of  restricted stock that could
revert to the  Company for  use under  the plan  if vesting  conditions are  not
satisfied).

                                       8
<PAGE>
DESCRIPTION OF PLAN

    ADMINISTRATION.

    The  Plan will be administered by a Committee  of two or more members of the
Board of Directors of the Company appointed by the Board. The Board of Directors
has  delegated  administration  to  the  Stock  Bonus  and  Compensation  Review
Committee  of the Board, none of the members of which is eligible to participate
in the  Plan. Among  other things,  the Committee  will have  the discretion  to
select  the form and timing of awards  under the Plan and the eligible employees
to whom awards are made.  The Committee also has  the authority, subject to  the
terms  of the Plan, to adopt rules and regulations to administer the Plan and to
interpret the Plan.

    ELIGIBILITY.  Officers, including executive  officers, and key employees  of
the  Company and its subsidiaries are eligible to receive awards under the Plan.
The Plan does not limit key employee  status to any particular class or  classes
of employees. Directors who are not employees are not eligible to participate in
the Plan.

    LIMITS.   An aggregate of 700,000 shares may be made subject to awards under
the Plan. If an  award lapses or  rights to the  award otherwise terminate,  the
shares subject to such award will be available for future awards under the Plan.
The  closing price of the Company's common  stock on the New York Stock Exchange
on April  5, 1994,  was  $33.00 per  share. The  Plan  prohibits the  making  of
additional  awards after 10 years have expired following shareholder approval of
the Plan.

    AWARDS.  Awards under the Plan may be made in the form of restricted  stock,
stock options, stock appreciation rights and performance shares.

    Restricted stock awards are awards of shares made without consideration from
the  recipient. The  Committee will establish  a restriction period  of not less
than one year from the  date of an award of  restricted stock, which period  may
phase  in  over a  period of  time after  the  first year.  If the  recipient is
discharged or terminates  employment during the  restriction period without  the
consent  of the Company, shares still subject  to the restriction period will be
returned to the Company. For termination  upon normal retirement (as defined  in
the Plan), death or disability or with the prior written consent of the Company,
a  prorated portion of the restricted shares  will be released to the recipient,
based on the time  served between the award  and such termination. Dividends  on
restricted  stock may, at the discretion of  the Committee, be paid currently to
the recipient or held  by the Company until  the restriction period expires.  In
the  latter case, the  Committee may allow  interest to be  paid on the withheld
dividends.

    Stock options granted under the Plan  may be either incentive stock  options
or  non-qualified options. In either case, the  exercise price of the option may
not be less than the fair market value  of the underlying shares as of the  date
of  grant.  Options become  exercisable during  the course  of a  vesting period
established by the Committee at the  date of grant. If employment is  terminated
during  the vesting  period, unvested  options will  expire; vested  options may
remain outstanding for periods  of as long as  two years following  termination,
depending  on the circumstances  of the termination  and the type  of option. An
option may not in any event be exercisable for more than ten years following the
date of grant.

    Incentive stock  options are  subject  to certain  additional  restrictions,
including  that the exercise price of options granted to a holder of ten percent
or more of the Company's common stock must be equal to at least 110% of the fair
market value; the  aggregate fair market  value of stock  with respect to  which
incentive  stock options  first become  exercisable in  any year  may not exceed
$100,000 (any additional  shares first becoming  exercisable in a  year will  be
treated as a non-qualified stock option); and such options must expire within 90
days  of  termination of  employment,  other than  termination  due to  death or
disability.

    A stock  appreciation right  ("SAR") allows  the holder,  upon exercise,  to
receive,  at the Committee's election, cash or  common stock equal to the amount
of the value  of the Company's  common stock at  the date of  exercise less  the
purchase price specified in the SAR. The purchase price may not be less than the
fair market value of the common stock at the date of issue of the SAR. SARs will
become  vested over periods of time established  by the Committee and shall have
such other terms,  including forfeiture  provisions, as are  established by  the
Committee.  SARs may be granted in tandem  with an option granted under the Plan
or

                                       9
<PAGE>
may be granted independently. SARs granted in tandem with an option will only be
exercisable when  the accompanying  option  is exercisable.  No SAR  may  remain
exercisable  for a period of more than ten years from the date of its grant. The
holder of a SAR has no voting, dividend or other rights of a shareholder.

    Performance shares  awards are  credited to  an account  maintained for  the
recipient.  An award period is  established with respect to  each grant, and the
amount of performance shares  earned over the period  is based on the  Company's
performance in terms of its return on equity over the award period or such other
criteria  as may be  established by the Committee  at the time  of the award. If
return on equity is used as the  performance measure, a minimum of a 10%  return
over  the award period  must be achieved for  the recipient to  earn 100% of the
awarded shares  and a  minimum of  a 7%  return over  the award  period must  be
achieved for the recipient to earn any awarded shares. The payout on performance
shares  is equal to the fair market value of  the common stock at the end of the
award period times the  number of performance shares  earned. The Committee  may
establish  a  fair  market  value  for each  award  period  for  the  purpose of
restricting the payment of  award shares, and  in no event  may the fair  market
value  used at the end of the award  period exceed 200% of the fair market value
at the beginning  of the period.  If the recipient  is discharged or  terminates
employment  during  an award  period  without the  consent  of the  Company, the
performance shares are forfeited. For termination upon normal retirement,  death
or  disability or  with the  prior written  consent of  the Company,  a prorated
portion of the award  shares will be paid  out at the end  of the award  period.
Payouts  are made in cash  or common stock of the  Company, with stock valued at
the current market  value at the  date of issuance.  A recipient of  performance
shares  has no voting, dividend or other rights of a shareholder until shares of
common stock are actually issued in payment of an award.

    The Committee has the  authority to accelerate  the restriction, vesting  or
award period of awards made under the Plan in the event of a public tender offer
for  the common stock of  the Company or of a  proposal to merge, consolidate or
otherwise combine with the Company.

    TRANSFERABILITY.    Interests   of  participants   in  the   Plan  are   not
transferable,  except in the event of a  participant's death and except that any
award other than  an incentive  stock option may  be transferred  pursuant to  a
qualified domestic relations order.

    AMENDMENTS  AND  TERMINATION.   The Board  of Directors  of the  Company may
terminate the Plan or, with the  consent of the affected participant, cancel  or
reduce  an outstanding award if it determines  that certain aspects of the award
are not in the best interests of  the Company. The Board of Directors may  amend
the  Plan at any time, provided that any  amendment of the Plan shall be subject
to approval of the Company's shareholders  to the extent required by  applicable
laws, regulations or rules. The Company intends that the Plan will qualify as an
employee  benefit plan  exempt from  the provisions  of the  reporting and short
swing profit recapture provisions of section  16 of the Securities Exchange  Act
of 1934 under Rule 16b-3. Rule 16b-3 requires that any amendment that materially
increases  the benefits accruing to  participants, that materially increases the
number of  securities that  may be  issued  under the  Plan or  that  materially
modifies the requirements for eligibility under the Plan must be approved by the
shareholders.

FEDERAL INCOME TAX CONSEQUENCES.

    A  recipient of restricted stock will recognize ordinary income in an amount
equal to the fair market  value of the shares on  the measurement date, and  the
amount of ordinary income recognized by the recipient generally is deductible by
the Company in the year that the income is recognized. The measurement date will
be  the date  on which the  restriction period terminates,  unless the recipient
elects to have the income determined and recognized as of the date of issuance.

    Dividends paid during the restriction period will be treated as follows.  If
the  above-described  election has  been made,  cash  dividends paid  during the
restriction period  but retained  by the  Company until  the expiration  of  the
restriction period will be taxable dividend income to the employee as of the end
of the restriction period; if the Committee allows cash dividends to be paid out
to   participants  during  the  restriction  period,  the  dividends  paid  will
constitute dividend income to  the employee when received.  In either case,  the
Company  will not be entitled to any  deduction. If the above described election
has not  been  made, cash  dividends  paid  during the  restriction  period  but
retained  by the Company until the end of the restriction period will be taxable
compensation income to the employee as of the end of the restriction period, and
the Company generally will be entitled  to a deduction for compensation paid  in
the same amount and at that

                                       10
<PAGE>
same  time.  If instead,  dividends  are paid  to  the recipient  throughout the
restriction period, then the employee will have taxable compensation income when
each dividend  is received,  and the  Company generally  will be  entitled to  a
deduction for compensation as each dividend is paid.

    The  grant of  an incentive stock  option should  have no tax  effect on the
Company or the optionee  to whom it  is granted, and there  generally is no  tax
upon  exercise of the option. The excess of  the fair market value of the shares
over the option price at the time  of exercise of an incentive stock option  may
subject  the  recipient to  alternative  minimum tax.  If  an optionee  does not
dispose of shares acquired upon exercise of  the option within two years of  the
date  of granting the option, nor within  one year after exercise of the option,
any gain  realized  by  the optionee  on  the  subsequent sale  of  such  shares
generally  is  treated  as  a  long-term capital  gain  for  federal  income tax
purposes. If  the  shares  are  sold  or otherwise  disposed  of  prior  to  the
expiration of such periods, the lesser of (a) the fair market value of the stock
at  the date of  exercise less the exercise  price and (b)  the gain realized on
disposition of the stock is treated  as compensation to the optionee taxable  as
ordinary  income. The excess gain, if any,  generally is treated as capital gain
which will be short-term or long-term capital gain depending upon the length  of
time  the shares were held. The Company generally is allowed a deduction for tax
purposes only to the extent,  and at the time, that  the optionee is treated  as
receiving  compensation income by reason of  the optionee's early disposition of
shares.

    The grant of a non-qualified stock  option or of a stock appreciation  right
also  should have no  tax effect on the  Company or the  recipient of the grant.
Generally, the spread  between the exercise  price and the  market value of  the
Company's  common stock  on the  date of exercise  of a  non-qualified option or
stock appreciation right is taxable as  ordinary income to the optionee. To  the
extent  the optionee  so realizes  ordinary income  the Company  generally has a
corresponding deduction.

    The grant of performance share  awards has no tax  effect on the Company  or
the  recipient at the  time of the grant.  The recipient of  any cash payment or
shares issued pursuant to the terms of a performance share award generally  will
recognize  ordinary income in an amount equal to the amount of such cash and the
fair market value  of such  shares as  of the date  of issuance.  The amount  of
ordinary  income  recognized by  the recipient  generally  is deductible  by the
Company in the year that the income is recognized.

    Compensation deductions by  the Company  in connection  with certain  awards
under  the Plan  to certain  executives may be  subject to  the recently enacted
$1,000,000 limitation on deductible compensation. In addition, if by reason of a
change in control of  the Company the  vesting of any awards  under the Plan  is
accelerated,  the value of the acceleration will be added to other payments made
to certain Plan  participants that are  contingent on the  change in control  in
determining whether the participant has received an excess parachute payment. If
any  benefit under the Plan received by a participant would constitute an excess
parachute payment, an excise  tax would be imposed  on the participant, and  the
Company would not receive a deduction for that amount.

PRIOR AWARDS.

    The  Plan does not require that awards,  or that awards of any specific size
or type, be  made to any  particular person  or persons. By  way of  background,
during the fiscal year ended January 27, 1994, 11,700 shares of restricted stock
were  awarded  under  the  1987  plan to  certain  key  employees.  None  of the
recipients of these awards was an executive officer or director of the  Company.
These  awards had a value of $429,975, based  on the average of the high and low
sale prices on the day the awards were approved.

    The foregoing summary of the principle  provisions of the Plan is  qualified
in  its entirety by reference to the full  text of the Plan annexed as Exhibit A
to this Proxy Statement.

                              FINANCIAL STATEMENTS

    The Annual Report  of the  Company, including financial  statements for  the
fiscal  year  ended  January  27,  1994, is  being  mailed  to  all shareholders
concurrently with the mailing of this  Proxy Statement. A copy of the  Company's
Form  10-K for  such fiscal year  may be  obtained without charge  by writing to
Longs Drug Stores Corporation, Attention:  Corporate Treasurer, 141 North  Civic
Drive, Walnut Creek, California 94596.

                                       11
<PAGE>
                          CERTIFIED PUBLIC ACCOUNTANTS

    The  firm of Deloitte  & Touche was engaged  as certified public accountants
for the  fiscal  year  ended  January  27, 1994.  The  Board  of  Directors,  on
recommendation  of its  Audit Committee, has  retained the firm  for the current
fiscal year. Representatives of Deloitte & Touche are expected to be present  at
the  Annual Meeting. They will  have an opportunity to  make a statement if they
desire to do so and will be available to respond to appropriate questions.

                SHAREHOLDER'S PROPOSALS FOR 1995 ANNUAL MEETING

    Under the  rules of  the  Securities Exchange  Commission,  in order  for  a
shareholder's  proposal to  be considered for  inclusion in  the Company's Proxy
Statement for the  1995 Annual Meeting  of Shareholders, such  proposal must  be
received  at  the Company's  Executive Offices  at 141  North Civic  Drive, Post
Office Box 5222,  Walnut Creek,  California 94596, no  later than  the close  of
business on December 16, 1994.

                                 OTHER MATTERS

    As  of the date of this Proxy Statement,  the Board of Directors knows of no
business other  than that  described above  to be  presented for  action at  the
meeting,  but it is intended  that all proxies will  be exercised upon any other
matters and  proposals  that  may  properly  come  before  the  meeting  or  any
adjournment  thereof,  in accordance  with the  direction  of the  persons named
therein.

                                       12
<PAGE>
                                   EXHIBIT A
                         LONGS DRUG STORES CORPORATION
                         1995 LONG-TERM INCENTIVE PLAN

1. PURPOSE

    The  purpose of  the 1995  Long-Term Incentive  Plan is  to provide  a means
through which Longs  Drug Stores  Corporation, a Maryland  Corporation, and  its
Subsidiaries,  may  attract and  retain the  employment of  able persons  and to
provide a means whereby  such persons can acquire  and maintain stock  ownership
thereby  strengthening their commitment to the welfare of the Company. A further
purpose of  the Plan  is to  provide  key employees  with incentive  and  reward
opportunities designed to enhance the profitable growth of the Company.

2. DEFINITIONS

    The following definitions shall be applicable throughout the Plan:

        a.    "Award" means,  individually  or collectively,  any  Option, Stock
    Appreciation Right (SAR), Restricted Stock Award or Performance Share Award.

        b.  "Award  Period" means  a period  of not  less than  three years  and
    relates to Performance Share Awards.

        c.  "Board" means the Board of Directors of the Company.

        d.  "Code" means the Internal Revenue Code of 1986, as amended from time
    to time. Reference in the Plan to any section of the Code shall be deemed to
    include  any  amendments or  successor provisions  to  such section  and any
    regulations under such section.

        e.  "Committee" means the committee of the Board appointed to administer
    the Plan as referred to in Section 4.

        f.  "Company" means Longs Drug Stores Corporation.

        g.  "Date of Grant" means the date on which the granting of an Award  is
    authorized  by the Committee or  such later date as  may be specified by the
    Committee in such authorization.

        h.  "Eligible Employee" means any person who satisfies the  requirements
    of Section 6.

        i.   "Fair  Market Value" means  the fair  market value of  Stock, to be
    determined as follows:

           (1) For Options  and SARs,  it shall be  the average  of the  highest
       price  and  the lowest  price at  which  the Stock  shall have  been sold
       regular way  on the  New York  Stock Exchange  -- Composite  Transactions
       (hereafter "NYSE") on a specified date.

           (2)  For Performance  Share Awards,  it shall  be the  average of the
       reported closing  prices of  the Stock  on the  NYSE for  30  consecutive
       trading  days prior to the "Valuation Date." The "Valuation Date" for the
       purpose of granting Performance  Share Awards shall be  the first day  of
       the year in which the Award is made. The "Valuation Date" for the purpose
       of  Performance Share Payments shall be  the first business day following
       the end of the Award Period.

        j.  "Holder" means a  person who has been granted  an Option, an SAR,  a
    Restricted Stock Award, or a Performance Share Award.

        k.   "Normal Retirement" means  Termination by resignation of employment
    with the Company and any Subsidiary after attaining age 65 or by resignation
    of employment with the Company and any Subsidiary after attaining age 60  if
    the   Committee  determines  that  such  resignation  constitutes  a  Normal
    Retirement for purposes of this Plan.

        l.  "Option" means an Award granted under Section 7 of the Plan.

        m. "Performance Share"  means an Award  granted under Section  9 of  the
    Plan.

                                      A-1
<PAGE>
        n.  "Plan" means this 1995 Long-Term Incentive Plan.

        o.   "Restricted Stock Award" means an Award granted under Section 10 of
    the Plan.

        p.  "ROE" means return on average shareholders' equity which is  defined
    as  the  Company's consolidated  net  earnings, before  extraordinary items,
    divided by the average of the shareholders' equity at the beginning and  end
    of  the  year,  as set  forth  in  the Company's  consolidated  statement of
    earnings and balance  sheet for such  year. The Committee  may, at its  sole
    discretion,  include  or  exclude  any  extraordinary  or  unusual  items in
    calculation of  ROE. "Average  ROE" means,  with respect  to any  one  Award
    Period,  the sum  of the ROE's  achieved in each  of the years  of the Award
    Period divided by the number of years in the Award Period.

        q.  "SEC" means the Securities and Exchange Commission.

        r.  "Stock" means Common Shares of the Company and, after  substitution,
    such other stock as shall be substituted therefor as provided in Section 12.

        s.    "Stock  Appreciation Right"  (SAR)  means an  Award  granted under
    Section 8, whether or not granted in conjunction with an Option.

        t.   "Subsidiary" means  any  corporation of  which  a majority  of  the
    outstanding  voting stock or voting power  is beneficially owned directly or
    indirectly by the Company.

        u.  "Termination" means,  with respect to any  person, ceasing to be  an
    employee of the Company or any Subsidiary, other than by death.

        v.   "Uninvited Change in Corporate Control" means any change in (i) the
    ownership or effective control of the Company or any Subsidiary, or (ii) the
    ownership of  a substantial  portion of  the assets  of the  Company or  any
    Subsidiary,  which is  not approved  by a majority  of the  directors of the
    Company who have been in office at least six (6) months prior to the date of
    such change.

3. EFFECTIVE DATE, DURATION AND SHAREHOLDER APPROVAL

    This Plan shall become effective as of the date of approval of this Plan  by
a  majority of the shareholders of  the Company present or otherwise represented
and entitled to vote at a duly convened meeting of shareholders. Subject to  the
provisions  of Section 13, Awards may be made as provided herein for a period of
10 years from the date  this Plan is so approved  by the shareholders. The  Plan
shall continue in effect until all matters relating to the payment of Awards and
administration of the Plan have been settled.

4. ADMINISTRATION

    The  Plan shall be administered by the Committee, which shall consist of two
or more members of the Board and shall be appointed by the Board. A majority  of
the Committee shall constitute a quorum.

    Subject  to the provisions  of the Plan, the  Committee shall have exclusive
power to:

        a.  Select the persons to participate in the Plan.

        b.  Determine the Awards to be made to each person selected.

        c.  Determine the time or times when Awards will be made.

        d.   Determine the  conditions (including  performance requirements)  to
    which the Awards may be subject.

        e.  Prescribe the form or forms evidencing Awards.

    The  Committee shall  have the authority,  subject to the  provisions of the
Plan, to establish, adopt, or revise such rules and regulations and to make  all
such  determinations relating to the Plan as  it may deem necessary or advisable
for the administration of the Plan.  The Committee's interpretation of the  Plan
or  any Awards granted pursuant thereto  and all decisions and determinations by
the Committee with respect to the  Plan shall be final, binding, and  conclusive
on all parties.

                                      A-2
<PAGE>
5. GRANT OF OPTIONS, STOCK APPRECIATION RIGHTS, RESTRICTED STOCK AWARDS, AND
   PERFORMANCE SHARE AWARDS; SHARES SUBJECT TO THE PLAN

    The  Committee may, from time  to time, grant Awards  to one or more persons
determined by it to be eligible for participation in the Plan in accordance with
the provisions of Section 6; provided however that:

        a.  TOTAL SHARES.  Subject to Section 12, the aggregate number of shares
    of Stock made subject to Awards may not exceed 700,000.

        b.  USE OF  SHARES.  Such shares  shall be deemed to  have been used  in
    payment  of Performance  Shares and SARs  whether actually  delivered or the
    Fair Market Value equivalent of such shares  is paid in cash. To the  extent
    that  an Award lapses or  the rights of its  Holder terminate, any shares of
    Stock subject to such  Award shall again  be available for  the grant of  an
    Award.

        c.  ELIGIBLE SHARES.  Stock delivered by the Company in settlement under
    the  Plan may be authorized and unissued Stock or Stock held in the treasury
    of the  Company  or may  be  purchased on  the  open market  or  by  private
    purchase.

6. ELIGIBILITY

    Officers  and  key employees  of the  Company  or a  Subsidiary who,  in the
opinion of the Committee,  are mainly responsible for  the continued growth  and
development  and  financial  success  of  the business  of  the  Company  or any
Subsidiary shall be eligible to be granted Awards under the Plan.

7. STOCK OPTIONS

    One or more Options can be granted to any Eligible Employee. Options may  be
granted  as Incentive Stock Options ("ISOs")  and nonqualified stock options and
shall be subject to the following conditions:

        a.  OPTION PRICE.  The option price  per share of Stock shall be set  by
    the  grant but shall  in no instance be  less than Fair  Market Value at the
    Date of Grant.

        b.  FORM OF  PAYMENT.  At the  time of the exercise  of the Option,  the
    option  price shall be payable in cash  and/or shares of Stock valued at the
    Fair Market Value at the time the Option is exercised, and at the discretion
    of and on terms acceptable to the Committee, by a note signed by the  Holder
    payable  to  the Company  providing  for simple  interest  at a  rate  to be
    stipulated by the Committee.

        c.  OTHER TERMS AND CONDITIONS.  Each Option shall become exercisable in
    cumulative installments in such  manner and within  such period or  periods,
    not  to exceed 10  years from its Date  of Grant, as set  forth in the Stock
    Option Agreement. No Option shall be exercisable after the expiration of ten
    years from the  date it is  granted. Except  as set forth  below, an  Option
    shall terminate in the event of the Holder's Termination or death.

    Unless  limited to  shorter periods  by the  Stock Option  Agreement, in the
event of a Termination, the Holder shall  have the right to exercise the  Option
for  the following periods after  such Termination, but only  to the extent that
the Option was exercisable at the date of the Termination and does not otherwise
expire by its terms.

           (1) In the event  of Normal Retirement, two  years after the date  of
       Termination.

           (2)  In the event of  (a) discharge by the  Company or any Subsidiary
       (except for theft or proven dishonesty) within two years from the date of
       an Uninvited  Change in  Corporate  Control, or  (b) resignation  of  the
       Holder  within  the  period  commencing  180 days  from  the  date  of an
       Uninvited Change in Corporate Control and ending two years from the  date
       of  an Uninvited Change in Corporate Control,  one year after the date of
       Termination.

           (3) In the event of the  Holder's Termination (except as provided  in
       Section  7c(2) hereof) with  the prior written consent  of the Company or
       any Subsidiary, three (3) months after the date of such resignation. Such
       prior written consent may be given only by the Chief Executive Officer of
       the

                                      A-3
<PAGE>
       Company or any  Subsidiary or  any such  officer delegated  by the  Chief
       Executive Officer (other than the resigning person) and must specify that
       it is given for the purpose of the Holder's exercise of the Option.

           (4)  In the event of  (a) discharge by the  Company or any Subsidiary
       with or without cause (except as  provided in Section 7c(2), hereof),  or
       (b)  resignation without the prior written  consent of the Company or any
       Subsidiary, on the date of such discharge or resignation.

    In the event of Holder's death prior to Termination, or within three  months
of  a Normal Retirement,  the Option may be  exercised for a  period of one year
after the date  of Holder's  death or,  if shorter,  the remaining  term of  the
Option.

        d.  SPECIAL RULES GOVERNING INCENTIVE STOCK OPTIONS
    (ISOS).  Notwithstanding the foregoing, any ISO granted under the Plan shall
    be  subject to such terms  and conditions not inconsistent  with the Plan as
    the Committee shall impose, including the following:

           (1) No individual  will be  granted an  ISO if  that individual  owns
       stock  of the Company or any of its Subsidiaries possessing more than ten
       percent of the total combined voting power of all classes of stock of the
       Company or any of its Subsidiaries, unless the option price shall not  be
       less  than 110% of the  Fair Market Value of such  stock on the date such
       Option is granted  and the Option  by its terms  is not exercisable  more
       than five years from the date it is granted;

           (2)  The aggregate Fair Market Value  (determined at the time the ISO
       is granted) of the stock with  respect to which ISOs are exercisable  for
       the  first  time  by  any  Holder during  any  calendar  year  (under all
       incentive stock option plans of  the Company) shall not exceed  $100,000;
       provided,  however, that all or any portion  of an Option which cannot be
       exercised as an  ISO because  of such limitation  shall be  treated as  a
       nonqualified stock option; and

           (3)  An ISO will not be  exercisable after 90 days after Termination,
       unless Termination is due to the  Holder's being disabled in which  event
       the  ISO will cease to be exercisable  one year after Termination. An ISO
       will not be exercisable after one year after the death of the Holder.

        e.  STOCK OPTION AGREEMENT.  Each Option granted under the Plan shall be
    evidenced by a "Stock Option Agreement"  between the Company and the  Holder
    of  the  Option  containing provisions  not  inconsistent with  the  Plan as
    determined  by  the  Committee,  and  shall  be  subject  to  the  following
    additional terms and conditions:

           (1)  Any  Option  or portion  thereof  that is  exercisable  shall be
       exercisable for  the full  amount  or for  any  part thereof,  except  as
       otherwise determined by the Stock Option Agreement.

           (2)  Each Option shall cease to be exercisable, as to any share, when
       the Holder purchases  the share or  exercises a related  SAR or when  the
       Option lapses.

           (3) Leaves of absence, approved by the Company or a Subsidiary, shall
       not constitute the termination of employment of the Holder.

        f.   EXPIRED OPTIONS.   If any  Options awarded under  the Plan shall be
    forfeited, cancelled, or not  exercised in full, the  Stock subject to  such
    Options may again be awarded under the Plan.

        g.  TENDER OFFER OR MERGER.  Notwithstanding any other provision, in the
    event of a public tender offer for all or any portion of the Stock or in the
    event  that a proposal to merge,  consolidate, or otherwise combine with, or
    sell all  or  a substantial  portion  of the  assets  of the  Company  or  a
    Subsidiary  to, another company  is submitted for  shareholder approval, the
    Committee may in its sole  discretion declare previously granted options  to
    be immediately exercisable.

8. STOCK APPRECIATION RIGHTS

    Any  Option granted under the Plan may include an SAR, either at the time of
grant or  by  amendment.  SARs may  also  be  granted to  an  Eligible  Employee
independent of any prior or contemporaneous Option

                                      A-4
<PAGE>
grant and shall be exercisable as provided therein without regard to any Option.
In  addition to such terms and conditions  not inconsistent with the Plan as the
Committee shall impose, SARs shall be subject to the following terms:

        a.   RIGHT  TO  EXERCISE.   An  SAR  granted with  an  Option  shall  be
    exercisable  to the extent and only to the extent the Option is exercisable.
    An SAR not  included in  an Option shall  have a  "purchase price"  ascribed
    thereto  by the Committee in granting such SAR, which shall not be less than
    the Fair Market Value of the Stock on the Date of Grant.

        b.  PAYMENT.  An exercisable  SAR shall entitle the Holder to  surrender
    unexercised  the SAR or the Option in which  it is included, as the case may
    be, or  any portion  thereof, and,  to receive  in exchange  therefore  that
    number  of  shares  of  Stock  having an  aggregate  Fair  Market  Value, as
    hereinafter defined, equal  to the excess  of the Fair  Market Value of  one
    share  over the  purchase price  per share specified  in such  SAR or Option
    times the number  of shares  called for  by the  SAR or  Option, or  portion
    thereof,  which is so surrendered. The  Committee shall be entitled to elect
    to settle the Company's obligation arising out of the exercise of an SAR  by
    the payment of cash or partially by the payment of cash and partially by the
    delivery  of shares, the total value of  which shall be in either case equal
    to the  aggregate Fair  Market Value  of the  shares it  would otherwise  be
    obligated  to deliver. The Committee shall also have the right to place such
    limitations and restrictions on the obligation to make such cash payments or
    deliver shares under SARs as it, in its sole discretion, deems to be in  the
    best  interest  of  the Company.  The  Fair  Market Value  for  SAR exercise
    purposes of shares shall be determined on the basis of prices on the trading
    day next preceding the  date on which  the SAR is  exercised. To the  extent
    that  an SAR included in an Option is exercised, such Option shall be deemed
    to have been exercised, and shall not be deemed to have lapsed.

        c.  SPECIAL  RULES GOVERNING SARS.   An  SAR not included  in an  Option
    shall  be evidenced by an agreement between  the Company and the Holder in a
    form approved by  the Committee.  Any SAR granted  under the  Plan shall  be
    subject  to such terms and conditions not  inconsistent with the Plan as the
    Committee shall impose, including the following:

           (1) The SAR will lapse no  later than the underlying Option for  SARs
       accompanying  an Option or, for freestanding SARs, no later than 10 years
       from its Date of Grant;

           (2) An SAR accompanying an Option may be exercised only when the Fair
       Market Value of the Stock exceeds  the option price of the Stock  subject
       to the SAR.

           (3) Such terms as the Committee determines are necessary or desirable
       to  qualify the SAR under Rule 16b-3  as promulgated by the SEC under the
       Securities  Exchange  Act  of  1934  for  those  Holders  to  whom   such
       qualification is relevant.

        d.   OTHER LIMITATIONS.   Such other limitations  as the Committee shall
    impose.

9. PERFORMANCE SHARES

    One or  more  Awards  of Performance  Shares  may  be made  to  an  Eligible
Employee. Performance Shares shall be credited to a Performance Share account to
be maintained for each such Holder. Each Performance Share shall be deemed to be
the  equivalent of one share  of Stock of the  Company. The Award of Performance
Shares under the Plan shall not entitle the Holder to any interest in or to  any
dividend, voting, or other rights of a shareholder. The value of the Performance
Shares  in a Holder's Performance Share account at the time of Award or the time
of payment shall  be the Fair  Market Value at  any such time  of an  equivalent
number  of shares of  the Stock (subject  to the limitation  provided in Section
9c).

    If any  Performance  Shares  awarded  under the  Plan  shall  be  forfeited,
cancelled, or not paid out in full, such Performance Shares may again be awarded
under the Plan. Shares of Stock delivered upon payment of Performance Shares may
be  either treasury shares, shares purchased  for the account of the participant
or authorized and unissued shares, or any combination thereof.

                                      A-5
<PAGE>
        a.  AWARD  GRANTS.   Grants of  Performance Shares  may be  made by  the
    Committee  in any fiscal year during the  term of the Plan. Such shares will
    be paid out in full or in part on the basis of the Company's performance  in
    terms  of  (i) ROE  over the  Award  Period following  the beginning  of the
    Company's fiscal year in which the Award is made as hereinafter set forth or
    (ii) such other criteria as determined by the Committee. In determining  the
    size   of  Awards,  the  Committee  shall   take  into  account  a  Holder's
    responsibility level, performance, potential,  cash compensation level,  and
    the  Fair Market Value of the Company's Stock at the time of Awards, as well
    as such other considerations as it deems appropriate.

    In the event a Holder terminates  employment during an Award Period,  payout
would be as follows:

           (1) Normal Retirement:

           Payout  would be  at the  end of  the Award  Period and  prorated for
           service during the period.

           (2) Resignation or discharge:

           For resignation with the  prior written consent of  the Company or  a
           Subsidiary,  the payout would be  at the end of  the Award Period and
           prorated for service  during the period.  For resignation other  than
           with  such consent  (and not  constituting Normal  Retirement) or for
           discharge with  or  without  cause, the  Award  would  be  completely
           forfeited.

           (3) Death or Disability:

           Payout  would be  at the  end of  the Award  Period and  prorated for
           service during the period.

    The Committee shall not,  over the entire Plan  period, grant to any  single
Holder  more than 15% of  the maximum number of  Performance Shares which may be
granted under the Plan. Awards cancelled or  portions of Awards not paid out  in
full  for  any  single  Holder  shall  not  be  included  for  purposes  of this
limitation.

    Grants of Performance Shares shall  be deemed to have  been on January 1  of
the year in which grants are made.

        b.   RIGHT TO PAYMENT  OF PERFORMANCE SHARES.   Following the end of the
    Award Period, the Holder of a Performance Share shall be entitled to receive
    payment of an amount  based on the achievement  of the performance  measures
    for  such Award Period, as determined  by the Committee. The Committee shall
    have the right  to establish  Average ROE  requirements; provided,  however,
    that  to  the extent  that the  performance  measure is  ROE over  the Award
    Period, such  requirements shall  not  reduce below  ten percent  (10%)  the
    Average  ROE necessary to earn  one hundred percent (100%)  of the Award and
    that any such reduction  shall be made  only during the  first half of  each
    Award  Period and shall not  exceed 4 percentage points  in total, and in no
    event shall payments be permitted for an Average ROE of less than 7 percent.

        c.  FORM AND TIMING OF PAYMENT.  No payment of Performance Shares  shall
    be made prior to the end of an Award Period. Payment therefore shall be made
    as  soon as  practicable after the  receipt of  audited financial statements
    relating to the last  year of such period.  The Committee may establish  for
    each  Award  Period  a  Fair  Market  Value  for  purposes  of  payments  of
    Performance Shares but in no event shall it exceed by more than two  hundred
    percent  (200%)  the Fair  Market  Value at  the  time of  granting  of such
    Performance Shares.

    The payment to  which a  Holder shall  be entitled at  the end  of an  Award
Period  shall be a dollar amount equal to the Fair Market Value at the Valuation
Date (as defined in Section 2i(2) hereof) of the number of shares of Stock equal
to the number of Performance Shares earned and payable to him in accordance with
Section 9b. Payment  shall normally  be made one-half  in cash  and one-half  in
Stock;  however, the Committee may authorize  payment in such other combinations
of cash and  Stock or  all in cash  or all  in Stock, as  it deems  appropriate.
Issuance of Stock shall be subject to the authorization of the Board.

                                      A-6
<PAGE>
    The  number of shares of Stock to be paid in lieu of cash will be determined
by dividing the portion of the payment not paid in cash by:

           (1) The price per  share of Stock (the  average of the highest  price
       and  the lowest price at which the Stock shall have been sold regular way
       on the NYSE) on the date on which the shares are issued; or

           (2) The price  per share  paid for  shares purchased  for a  Holder's
       account should the Board of Directors determine to authorize the purchase
       of shares on behalf of a holder.

        d.   TENDER OFFER OR MERGER.  Notwithstanding any other provision of the
    Plan, in the event of any public tender offer for all or any portion of  the
    Stock  or in the  event that a  proposal to merge,  consolidate or otherwise
    combine with, or  sell all or  a substantial  portion of the  assets of  the
    Company  or a  Subsidiary to, another  company is  submitted for shareholder
    approval, the Committee may in its sole discretion declare any Award  Period
    ended  as of  a specific  date and accelerate  full payments  of such awards
    accordingly. For  awards based  on  ROE, the  Committee shall  determine  an
    Average  ROE  for the  reduced Award  Period  and may  estimate ROE  for any
    periods for which annual reports are not yet available.

10. RESTRICTED STOCK AWARDS

        a.  RESTRICTION PERIOD TO BE ESTABLISHED BY THE COMMITTEE.  One or  more
    Awards  of Restricted Stock may be made to an Eligible Employee. At the time
    a Restricted Stock Award is made, the Committee shall establish a period  of
    time  (the "Restriction Period") applicable to such Award which shall be not
    less than one  (1) year. Each  Restricted Stock Award  may have a  different
    Restriction  Period, at the discretion  of the Committee. In  the event of a
    public tender offer for all or any portion of the Stock or in the event that
    any proposal to merge, consolidate or otherwise combine with, or sell all or
    a substantial  portion of  the assets  of the  Company or  a Subsidiary  to,
    another  company is  submitted for approval,  the Committee may  in its sole
    discretion change or eliminate the  Restriction Period. Except as  permitted
    above  or pursuant  to Section  12, the  Restriction Period  applicable to a
    particular Restricted Stock Award shall not be changed.

        b.  OTHER TERMS AND CONDITIONS.  Stock awarded pursuant to a  Restricted
    Stock  Award shall be  represented by a stock  certificate registered in the
    name of the Holder of such Restricted Stock Award. The Holder shall have the
    right to enjoy all shareholder rights during the Restriction Period with the
    exception that:

           (1) The  Holder  shall not  be  entitled  to delivery  of  the  stock
       certificate until the Restriction Period shall have expired.

           (2)  The Company may either issue  shares subject to such restrictive
       legends and/or  stop-transfer instructions  as  it deems  appropriate  or
       provide  for retention  of custody  of the  Stock during  the Restriction
       Period.

           (3) A breach of the terms and conditions established by the Committee
       pursuant to the Restricted  Stock Award shall cause  a forfeiture of  the
       Restricted Stock Award, and any dividends withheld thereon.

           (4) Cash and stock dividends may be either currently paid or withheld
       by  the Company  for the  Holder's account  until the  Restriction Period
       expires. At the discretion of the Committee, interest may be paid on  the
       amount  of  cash dividends  withheld, including  cash dividends  on stock
       dividends, at  a rate  and subject  to such  terms as  determined by  the
       Committee.

                                      A-7
<PAGE>
        c.   FORFEITURE PROVISIONS.  In the event a Holder terminates employment
    during a Restriction Period, an Award would be forfeited as follows:

           (1) Normal Retirement:

           The Award would be prorated for  service during the period and  would
           be received as soon as practicable following retirement.

           (2) Resignation or discharge:

           For  resignation with the  prior written consent of  the Company or a
           Subsidiary, the Award would be prorated for service during the period
           and received  as  soon  as  practicable  following  resignation.  For
           resignation other than with such consent (and not constituting Normal
           Retirement)  or for discharge with or  without cause, the Award would
           be completely forfeited.

           (3) Death or Disability:

           The Award  would  be  prorated  for service  during  the  period  and
           received as soon as practicable following death or disability.

    Dividends  withheld by  the Company  on Restricted  Stock that  is forfeited
shall be retained by the Company.

        d.  PAYMENT FOR  RESTRICTED STOCK.   A Holder shall  not be required  to
    make any payment for Stock received pursuant to a Restricted Stock Award.

11. GENERAL

        a.   GOVERNMENT AND OTHER REGULATIONS.  The obligation of the Company to
    make payment  of  Awards in  Stock  or otherwise  shall  be subject  to  all
    applicable   laws,  rules,  and  regulations,   and  to  such  approvals  by
    governmental agencies as  may be  required. The  Company shall  be under  no
    obligation  to register under the Securities Act of 1933, as amended ("Act")
    any of the shares of stock paid under the Plan. If the shares paid under the
    Plan may in certain circumstances be exempt from registration under the Act,
    the Company may restrict the  transfer of such shares  in such manner as  it
    deems advisable to ensure the availability of any such exemption.

        b.  TAX WITHHOLDING.  The Company or a Subsidiary, as appropriate, shall
    have  the right to deduct from all Awards paid in cash any federal, state or
    local taxes as  required by law  to be  withheld with respect  to such  cash
    payments.  In the case of Awards paid in Stock, the employee or other person
    receiving such Stock may be required to pay to the Company or a  Subsidiary,
    as appropriate, the amount of any such taxes which the Company or Subsidiary
    is required to withhold with respect to such Stock.

        c.   CLAIM TO AWARDS AND EMPLOYMENT RIGHTS.  No employee or other person
    shall have any claim or right to be granted an Award under the Plan. Neither
    this Plan nor any  action taken hereunder shall  be construed as giving  any
    employee  any  right  to be  retained  in the  employ  of the  Company  or a
    Subsidiary or limit the right of the Company or any Subsidiary to  terminate
    an  employee  at anytime,  with  or without  cause.  A holder  of  any right
    hereunder to receive cash  or Stock in  respect of any  Award shall have  no
    rights  other  than  those of  a  general  creditor of  the  Company. Awards
    represent unfunded and unsecured obligations of the Company, subject to  the
    terms and conditions of the applicable Award.

        d.   BENEFICIARIES.   Any  payment of  Awards due  under this  Plan to a
    deceased Holder shall  be paid  to the  beneficiary duly  designated by  the
    Holder  in accordance with  the Company's practices.  If no such beneficiary
    has been designated  or survives the  Holder, payment shall  be made to  the
    Holder's  legal representative. A beneficiary  designation may be changed or
    revoked by a Holder at any time  provided the change or revocation is  filed
    with the Committee.

        e.  NONTRANSFERABILITY.  A person's rights and interests under the Plan,
    including  any Award previously  made to such person  or any amounts payable
    under the Plan, may not be assigned, pledged, or transferred except, in  the
    event of an employee's death, to a designated beneficiary as provided in the

                                      A-8
<PAGE>
    Plan,  or in the absence of such designation, by will or the laws of descent
    and distribution, or, for any Award other than an ISO (or an SAR granted  in
    tandem  with an  ISO), pursuant to  a qualified domestic  relations order as
    defined by the Code  or Title I of  the Employee Retirement Income  Security
    Act, or the rules thereunder.

        f.   INDEMNIFICATION.  Each person who is or shall have been a member of
    the Committee or of the Board shall be indemnified and held harmless by  the
    Company  from and against any loss, cost,  liability, or expense that may be
    imposed upon or reasonably incurred by  him in connection with or  resulting
    from any claim, action, suit, or proceeding to which he may be a party or in
    which he may be involved by reason of any action or failure to act under the
    Plan and against and from any and all amounts paid by him in satisfaction of
    judgment  in any such action, suit, or proceeding against him. He shall give
    the Company an  opportunity, at its  own expense, to  handle and defend  the
    same  before he undertakes  to handle and  defend it on  his own behalf. The
    foregoing right  of indemnification  shall  not be  exclusive of  any  other
    rights  of indemnification to  which such persons may  be entitled under the
    Company's Articles  of Incorporation  or By-Laws,  as a  matter of  law,  or
    otherwise,  or any power that the Company may have to indemnify them or hold
    them harmless.

        g.  RELIANCE ON REPORTS.  Each  member of the Committee and each  member
    of  the Board shall  be fully justified  in relying or  acting in good faith
    upon any report made by the independent public accountant of the Company and
    its Subsidiaries and upon any other information furnished in connection with
    the Plan by any person or persons other than himself. In no event shall  any
    person  who is or shall have been a  member of the Committee or of the Board
    be liable for any determination made  or other action taken or any  omission
    to  act in reliance  upon any such  report or information  or for any action
    taken, including the  furnishing of information,  or failure to  act, if  in
    good faith.

        h.   RELATIONSHIP TO OTHER BENEFITS.  No payment under the Plan shall be
    taken  into  account  in  determining   any  benefits  under  any   pension,
    retirement,  profit sharing,  group insurance or  other benefit  plan of the
    Company or any Subsidiary.

        i.  EXPENSES.  The expenses of administering the Plan shall be borne  by
    the Company and its Subsidiaries.

        j.   PRONOUNS.   Masculine pronouns and other  words of masculine gender
    shall refer to both men and women.

        k.  TITLES AND HEADINGS.  The titles and headings of the sections in the
    Plan are  for  convenience  of reference  only,  and  in the  event  of  any
    conflict,  the text of the Plan, rather  than such titles or headings, shall
    control.

12. CHANGES IN CAPITAL STRUCTURE

    Options, SARs, Restricted  Stock Awards,  Performance Share  Awards and  any
agreements  evidencing  such  Awards  shall  be  subject  to  adjustment  by the
Committee as to the number and price per share of Stock or other  considerations
subject  to such  Awards in  the event  of changes  in the  outstanding Stock by
reason of  stock dividends,  stock splits,  recapitalizations,  reorganizations,
mergers,  consolidations, combinations, exchanges, or  other relevant changes in
capitalization occurring after  the Date  of Grant of  any such  Awards. In  the
event  of any  such change  in the  outstanding Stock,  the aggregate  number of
shares  available  under  the  Plan  shall  be  appropriately  adjusted  by  the
Committee, whose determination shall be conclusive.

13. AMENDMENTS AND TERMINATION

    The  Board may at any  time terminate the Plan  or, with the express written
consent of an individual  participant, cancel or reduce  or otherwise alter  his
outstanding Awards thereunder if, in its judgment, the tax, accounting, or other
effects  of the Plan  or potential payouts  thereunder would not  be in the best
interest of the Company. The Board may, at any time, or from time to time, amend
or suspend and, if suspended, reinstate, the Plan in whole or in part, provided,
however, that any amendment of the Plan shall be subject to the approval of  the
Company's shareholders to the extent required by applicable laws, regulations or
rules.

                                      A-9
<PAGE>
14. CLAIMS PROCEDURES

    Claims  for  benefits under  the Plan  shall  be filed  in writing  with the
Committee on forms supplied by the Committee. Written notice of the  disposition
of  a claim shall be furnished to the claimant within 90 days after the claim is
filed. If the claim  is denied, the  notice of disposition  shall set forth  the
specific  reasons for the  denial, citations to the  pertinent provisions of the
Plan, and, where appropriate, an explanation as to how the claimant can  perfect
the claim. If the claimant wishes further consideration of his or her claim, the
claimant  may appeal a denied claim to  the Committee (or to a person designated
by the Committee) for further review. Such appeal shall be filed in writing with
the Committee  on a  form supplied  by the  Committee, together  with a  written
statement of the claimant's position, no later than 90 days following receipt by
the  claimant  of written  notice of  the denial  of  his or  her claim.  If the
claimant so requests,  the Committee  shall schedule  a hearing.  A decision  on
review  shall be made  after a full  and fair review  of the claim  and shall be
delivered in writing to the claimant no later than 60 days after the Committee's
receipt of the  notice of  appeal, unless special  circumstances (including  the
need  to hold a hearing) require an extension of time for processing the appeal,
in which case a written decision on review shall be delivered to the claimant as
soon as possible but not  later than 120 days  after the Committee's receipt  of
the  appeal  notice. The  claimant  shall be  notified  in writing  of  any such
extension of time. The written decision on review shall include specific reasons
for the  decision,  written in  a  manner calculated  to  be understood  by  the
claimant, and shall specifically refer to the pertinent Plan provisions on which
it  is based. All determinations of the  Committee shall be final and binding on
Participants and their beneficiaries.

                                      A-10
<PAGE>

PROXY CARD                                                            PROXY CARD
                         LONGS DRUG STORES CORPORATION
                141 NORTH CIVIC DRIVE, WALNUT CREEK, CALIFORNIA

                  ANNUAL MEETING OF SHAREHOLDERS--MAY 17, 1994

          THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS.

The undersigned appoints R.M. LONG, S.D. ROATH, R.A. PLOMGREN and each of them
proxies for the undersigned, with the powers the undersigned would possess if
personally present and with full power of substitution to act and to vote, as
designated below, all the shares of the undersigned in Longs Drug Stores
Corporation, at the Annual Meeting of its Shareholders to be held on Tuesday,
May 17, 1994, at 11:00 A.M., and at any adjournment thereof.

                                                                See Reverse Side
<PAGE>

THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER DIRECTED HEREIN
BY THE UNDERSIGNED STOCKHOLDER.

IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR ALL NOMINEES NAMED IN
PROPOSAL 1 AND IN FAVOR OF PROPOSAL 2.

/x/ Please mark your choices like this

- ------------------------
         Common

1.  ELECTION OF DIRECTORS as listed below
(except as marked to the contrary below)

    FOR / /          WITHHOLD AUTHORITY / /

(INSTRUCTION: To withhold authority to vote for any individual nominee, strike a
line through the nominee's name below.)

E.E. Johnston     M.S. Metz     S.D. Roath     T.R. Sweeney

2.  Approval of 1995 Long-Term Incentive Plan.
    FOR / /           AGAINST / /          ABSTAIN / /

3.  In their discretion, the Proxies are authorized to vote upon such other
    business as may properly come before the meeting, or any adjournment
    thereof, including matters which the Board of Directors do not at this time
    know are to be presented at the meeting.

I PLAN TO ATTEND MEETING  / /

Please sign exactly as name appears below. If the stock is of record in the
names of two or more persons, one of them may sign the proxy. A proxy executed
by a corporation or a partnership should be signed in its name by an authorized
person. Executors, administrators, guardians, conservators, and custodians
should so indicate when signing.

DATED:                                                                     ,1994
      ---------------------------------------------------------------------


- --------------------------------------------------------------------------------
Signature of shareholder


- --------------------------------------------------------------------------------
Signature of shareholder

PLEASE MARK, SIGN, DATE, AND RETURN THE PROXY CARD
PROMPTLY USING THE ENCLOSED ENVELOPE.


<PAGE>

PROXY CARD                                                            PROXY CARD

                          LONGS DRUG STORES CORPORATION
                 141 NORTH CIVIC DRIVE, WALNUT CREEK, CALIFORNIA

                   ANNUAL MEETING OF SHAREHOLDERS--MAY 17, 1994

          THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS.

The undersigned appoints R.M. LONG, S.D. ROATH, R.A. PLOMGREN and each of them
proxies for the undersigned, with the powers the undersigned would possess if
personally present and with full power of substitution to act and to vote, as
designated below, all the shares of the undersigned in Longs Drug Stores
Corporation, at the Annual Meeting of its Shareholders to be held on Tuesday,
May 17, 1994, at 11:00 A.M., and at any adjournment thereof.

                                                                See Reverse Side
<PAGE>

THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER DIRECTED HEREIN
BY THE UNDERSIGNED STOCKHOLDER.

IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR ALL NOMINEES NAMED IN
PROPOSAL 1 AND IN FAVOR OF PROPOSAL 2.

/x/ Please mark your choices like this

- ------------------------     ------------------------
     PROFIT SHARING                    V.I.P.

1.  ELECTION OF DIRECTORS as listed below
(except as marked to the contrary below)

    FOR / /          WITHHOLD AUTHORITY / /

(INSTRUCTION: To withhold authority to vote for any individual nominee, strike a
line through the nominee's name below.)

E.E. Johnston     M.S. Metz     S.D. Roath     T.R. Sweeney

2.  Approval of 1995 Long-Term Incentive Plan.
    FOR / /          AGAINST / /          ABSTAIN / /

3.  In their discretion, the Proxies are authorized to vote upon such other
    business as may properly come before the meeting, or any adjournment
    thereof, including matters which the Board of Directors do not at this time
    know are to be presented at the meeting.

I PLAN TO ATTEND MEETING  / /

Please sign exactly as name appears below. If the stock is of record in the
names of two or more persons, one of them may sign the proxy. A proxy executed
by a corporation or a partnership should be signed in its name by an authorized
person. Executors, administrators, guardians, conservators, and custodians
should so indicate when signing.

DATED:                                                                     ,1994
      ---------------------------------------------------------------------


- --------------------------------------------------------------------------------
Signature of shareholder


- --------------------------------------------------------------------------------
Signature of shareholder

PLEASE MARK, SIGN, DATE, AND RETURN THE PROXY CARD
PROMPTLY USING THE ENCLOSED ENVELOPE.


<PAGE>

PROXY CARD                                                            PROXY CARD
                         LONGS DRUG STORES CORPORATION
                141 NORTH CIVIC DRIVE, WALNUT CREEK, CALIFORNIA

                  ANNUAL MEETING OF SHAREHOLDERS-MAY 17, 1994

          THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS.

The undersigned appoints R.M. LONG, S.D. ROATH, R.A. PLOMGREN and each of them
proxies for the undersigned, with the powers the undersigned would possess if
personally present and with full power of substitution to act and to vote, as
designated below, all the shares of the undersigned in Longs Drug Stores
Corporation, at the Annual Meeting of its Shareholders to be held on Tuesday,
May 17, 1994, at 11:00 A.M., and at any adjournment thereof.

                                                                See Reverse Side
<PAGE>

THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER DIRECTED HEREIN
BY THE UNDERSIGNED STOCKHOLDER.

IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR ALL NOMINEES NAMED IN
PROPOSAL 1 AND IN FAVOR OF PROPOSAL 2.

/x/ Please mark your choices like this

- ------------------------
 RESTRICTED STOCK AWARD

1.  ELECTION OF DIRECTORS as listed below
(except as marked to the contrary below)

    FOR / /          WITHHOLD AUTHORITY / /

(INSTRUCTION: To withhold authority to vote for any individual nominee, strike
a line through the nominee's name below.)

E.E. Johnston     M.S. Metz     S.D. Roath     T.R. Sweeney

2.  Approval of 1995 Long-Term Incentive Plan.
    FOR / /          AGAINST / /          ABSTAIN / /

3.  In their discretion, the Proxies are authorized to vote upon such other
    business as may properly come before the meeting, or any adjournment
    thereof, including matters which the Board of Directors do not at this time
    know are to be presented at the meeting.

I PLAN TO ATTEND MEETING  / /

Please sign exactly as name appears below. If the stock is of record in the
names of two or more persons, one of them may sign the proxy. A proxy executed
by a corporation or a partnership should be signed in its name by an authorized
person. Executors, administrators, guardians, conservators, and custodians
should so indicate when signing.

DATED:                                                                    , 1994
      --------------------------------------------------------------------


- --------------------------------------------------------------------------------
Signature of shareholder


- --------------------------------------------------------------------------------
Signature of shareholder

PLEASE MARK, SIGN, DATE, AND RETURN THE PROXY CARD
PROMPTLY USING THE ENCLOSED ENVELOPE.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission